ORLANDO, Florida ― Initiating unobserved buprenorphine induction to treat opioid dependence may help lower barriers to care in this population, new research suggests. Results from an observational ...
The ISTART (Induction, STabilization, Adherence and Retention) Trial (Study OX219-006) was a randomized, non-inferiority, multicenter study to assess early treatment efficacy of Zubsolv versus generic ...
Please provide your email address to receive an email when new articles are posted on . Patients with untreated opioid use disorder responded well to a high-dose induction of buprenorphine in the ED, ...
High-dose buprenorphine therapy, provided under emergency department care, is safe and well tolerated in people with opioid use disorder experiencing opioid withdrawal symptoms, according to a study ...
High-dose buprenorphine therapy, provided under emergency department care, is safe and well tolerated in people with opioid use disorder experiencing opioid withdrawal symptoms, according to a study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results